Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Agilent Technologies and NUS Sign Research Collaboration Agreement for Lipidomics Research

Published: Thursday, March 31, 2011
Last Updated: Wednesday, March 30, 2011
Bookmark and Share
Partnership marks Agilent’s first collaboration in lipidomics research and development worldwide.

Agilent Technologies Inc. and the National University of Singapore have announced an agreement to develop expertise and knowledge in the area of analytical lipidomics. The goal of the partnership is to develop workflow solutions that enable researchers to more accurately understand disease states.

Under the terms of the agreement, Agilent’s provision of sophisticated test and measurement instruments will be housed in the NUS Center for Lipidomics within the university’s Life Sciences Institute. Headed by Associate Professor Markus Wenk, NUS Department of Biochemistry and Department of Biological Sciences, this center will host researchers and scientists from clinical and commercial organizations in Singapore and the Asia Pacific region. The center grew out of a competitive five-year research program and promises to be a global magnet for collaborating parties in lipidomics.

The collaboration will help to further advances in the emerging field of lipidomics, which may lead to the creation of new classes of biomedical research tools and therapies. The NUS Industry Liaison Office has been actively guiding the researchers and facilitating their work with industry to create win-win relationships with companies such as Agilent.

“Integrated tool development programs, such as this new Center for Lipidomics, greatly support applications in life and environmental sciences,” said Professor Barry Halliwell, NUS deputy president (Research and Technology). “We are delighted by the substantial industry interest and welcome Agilent as a partner in this endeavor.”

Agilent will support NUS with highly specialized instruments for the separation and analysis of lipids from complex mixtures using robotic systems and the latest bioinformatics software tools and electronic lab notebooks. The company will also provide NUS access to its scientists in Asia and the United States. NUS will serve as a reference site for Agilent and allow the company to better understand the needs of the research community. Agilent will use what it learns to further develop and enhance its instruments.

“Lipids play crucial roles in pathophysiology,” said Professor John Wong, dean of the NUS Yong Loo Lin School of Medicine. “The close proximity of this new center to clinical research and patient care at the National University Health System places us in a unique position for knowledge creation and translation in biomedicine.”

Additionally, both Agilent and NUS have agreed to explore opportunities in the field of lipidomics through collaborative research projects, short-term consultancies, customized training programs and workshops, and participation at industry seminars and conferences to advance the level of knowledge in the field of lipidomics.

“This strategic partnership with NUS will raise the level of knowledge for lipidomics and potentially pave the way for developments in related fields of research such as life sciences, nutritional sciences or environment sciences,” said Rod Minett, Agilent’s general manager, Life Sciences Group, South Asia Pacific and Korea. “We will collect insights into the use of our instruments in this complex research field and look to further develop and enhance our capabilities, not only in lipidomics but also in related fields of research.”

“This collaboration will further strengthen Agilent’s worldwide leadership in the field of metabolomics, which is a key strategic initiative for our company,” said Rudolf Grimm, Ph.D., Agilent’s director of science and technology and collaborations manager, Asia Pacific.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent Completes Acquisition of Seahorse Bioscience
Agilent has completed the acquisition of Seahorse Bioscience, a leader in providing instruments and assay kits for measuring cell metabolism and bioenergetics.
Tuesday, November 03, 2015
Agilent Announces Opening of Life Science Research Center
Facility designed to advance multi-omics research.
Thursday, September 24, 2015
Agilent to Acquire Seahorse Bioscience
Acquisition complements Agilent’s market-leading separations and mass spectrometry solutions, expands pharma offerings.
Thursday, September 10, 2015
Agilent to Focus on "Powerful Partnerships, Inspiring Results" at ASMS 2015
Company to introduce solutions enabling new standards in mass spectrometry, lab productivity.
Friday, May 29, 2015
Agilent, Baylor Open Mass Spec Center of Excellence
The new facility aims to boost metabolomics research at Baylor College of Medicine.
Friday, December 05, 2014
Agilent Thought Leader Award Supports Metabolic Research
Princeton team developing LC/MS methods, bioinformatics tools for discovery of metabolic regulatory mechanisms.
Tuesday, April 22, 2014
Agilent to Host Young Scientist Forums in Asia Pacific
Events provide platform for rising talents in Australia, Singapore to exchange ideas with leading scientific scholars.
Wednesday, March 26, 2014
Agilent, CambTEK Announce LC Sample Prep Agreement
Companies announce agreement to co-market CambTEK's RES automated sample preparation technology with an assortment of Agilent's instruments and software.
Wednesday, February 26, 2014
Agilent Awards Grant for Translational Research in Cardiometabolic Disease
Dr. Christopher Newgard's team at Duke University use Agilent platforms to better understand disease mechanisms.
Thursday, January 16, 2014
Agilent Thought Leader Award Supports Dr. Junying Yuan, Chinese Academy of Sciences
Integrated biological research is accelerating drug development for neurodegenerative diseases.
Wednesday, December 11, 2013
Agilent Reports Fourth-Quarter Results
Agilent Technologies reported orders up 4 percent over one year ago to $1.83 billion with revenues of $1.72 billion, down 3 percent compared with one year ago.
Monday, November 18, 2013
Agilent Recognized as 2013 Laboratory Analytical Instrumentation Company of the Year in China
The company ranked highest in industry for leadership, growth, innovation and customer service by Frost & Sullivan.
Tuesday, August 20, 2013
Agilent and SRI International Sign Licensing Agreement
Agilents’ new pathway Architect software to include SRI International’s BioCyc Pathway database collection.
Wednesday, April 17, 2013
Agilent and Spain’s Centre for Omic Sciences to Collaborate
Both Companies collaborate on integrated systems biology research, establish centre of excellence.
Tuesday, March 05, 2013
Agilent Technologies Thought Leader Award Supports Translational Research Program
The award will support Dr DePinho's research into metabolic reprogramming in the earliest stages of cancer.
Monday, March 04, 2013
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Circadian Clock Controls Insulin and Blood Sugar in Pancreas
Map of thousands of genes suggests new therapeutic targets for diabetes.
Cellular Stress Process Identified in Cardiovascular Disease
Combining the investigative tools of genetics, transcriptomics, epigenetics and metabolomics, a Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease.
Predicting Adverse Drug Reactions with Higher Confidence
A new integrated computational method helps predicting adverse drug reaction—which are often lethal—more reliably than with traditional computing methods.
A New Way to Starve Lung Cancer?
Metabolic alterations in lung cancer may open new avenues for treating the disease.
Evidence of How Incurable Cancer Develops
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder.
Building a Better Liposome
Computational models suggest new design for nanoparticles used in targeted drug delivery.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Antioxidants Cause Malignant Melanoma to Metastasize Faster
Fresh research at Sahlgrenska Academy has found that antioxidants can double the rate of melanoma metastasis in mice.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos